|
Jun 5
|
Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know
|
|
Jun 3
|
Is Grifols (GRFS) Stock Undervalued Right Now?
|
|
Jun 2
|
GRFS vs. STVN: Which Stock Is the Better Value Option?
|
|
May 30
|
US court proceeds with Grifols defamation case against Gotham City, but narrows scope
|
|
May 28
|
ADMA Biologics vs. Grifols: Which Plasma Therapy Stock Is the Better Buy?
|
|
May 22
|
FDA clears Grifols’ application for dry eye disease treatment
|
|
May 15
|
GRFS or NBIX: Which Is the Better Value Stock Right Now?
|
|
May 14
|
High Growth Tech Stocks in Europe for May 2025
|
|
Apr 2
|
European Equities Close Lower in Wednesday Trading; Brookfield in Talks Again to Acquire Grifols
|
|
Apr 2
|
Spanish pharma company Grifols' shares up on Brookfield talk
|
|
Mar 10
|
High Growth Tech Stocks in Europe for March 2025
|
|
Feb 27
|
Is Grifols, S.A. (GRFS) the Best Low Price Pharma Stock to Invest In Right Now?
|
|
Feb 27
|
Grifols SA (GIFLF) (Q4 2024) Earnings Call Highlights: Record Revenues and Strategic ...
|
|
Jan 2
|
Exploring Three High Growth Tech Stocks For Future Potential
|
|
Oct 3
|
High Growth Tech Stocks To Watch In October 2024
|
|
Oct 3
|
GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat
|
|
Sep 30
|
Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say
|
|
Sep 25
|
Sector Update: Health Care Stocks Fall Late Afternoon
|
|
Sep 19
|
Grifols Investor Group With 7.7% Holding Seeks Seat on Board
|
|
Sep 10
|
Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’
|